- Home
- SGMT vs DIT Comparison
SGMT vs DIT Comparison
Compare SGMT & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- DIT
- Stock Information
- Founded
- SGMT 2006
- DIT 1981
- Country
- SGMT United States
- DIT United States
- Employees
- SGMT N/A
- DIT N/A
- Industry
- SGMT
- DIT Food Distributors
- Sector
- SGMT
- DIT Consumer Discretionary
- Exchange
- SGMT Nasdaq
- DIT Nasdaq
- Market Cap
- SGMT 71.2M
- DIT 78.7M
- IPO Year
- SGMT 2023
- DIT 1995
- Fundamental
- Price
- SGMT $3.55
- DIT $112.82
- Analyst Decision
- SGMT Strong Buy
- DIT
- Analyst Count
- SGMT 6
- DIT 0
- Target Price
- SGMT $25.67
- DIT N/A
- AVG Volume (30 Days)
- SGMT 392.3K
- DIT 117.0
- Earning Date
- SGMT 05-08-2025
- DIT 07-17-2025
- Dividend Yield
- SGMT N/A
- DIT 0.63%
- EPS Growth
- SGMT N/A
- DIT N/A
- EPS
- SGMT N/A
- DIT 2.44
- Revenue
- SGMT N/A
- DIT $2,221,421,072.00
- Revenue This Year
- SGMT N/A
- DIT N/A
- Revenue Next Year
- SGMT N/A
- DIT N/A
- P/E Ratio
- SGMT N/A
- DIT $46.29
- Revenue Growth
- SGMT N/A
- DIT 7.47
- 52 Week Low
- SGMT $1.73
- DIT $99.87
- 52 Week High
- SGMT $7.38
- DIT $166.00
- Technical
- Relative Strength Index (RSI)
- SGMT 57.81
- DIT 45.66
- Support Level
- SGMT $3.18
- DIT $111.56
- Resistance Level
- SGMT $3.85
- DIT $113.42
- Average True Range (ATR)
- SGMT 0.27
- DIT 2.10
- MACD
- SGMT 0.01
- DIT 0.12
- Stochastic Oscillator
- SGMT 61.04
- DIT 32.34
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.